The Speech Improvement Company is the firm that executives from biotech start-ups count on to help them train for, develop, and deliver winning presentations to critically important businesspeople. We specialize in biotech and work with management teams at biotech start-ups to help them secure funding, by transforming technical information into compelling business presentations that truly resonate with investors.
“We were prepping for our IPO and many of the people we would encounter did not have a scientific background. So the most important thing we did was to simplify, stay above the details. That meant we had to learn the background of the people we were going to meet with and then adapt the presentation for different audiences. We received positive feedback as a result. It’s a great feeling to know that you conveyed your story to the audience successfully.”
– Frank DeRosa, Senior VP, Research and Process Development, Translate Bio
Your management team may be new to delivering presentations to non-technical business listeners, or they simply may benefit from advancing their presentation skills to the next level. Through our experience working with numerous biotech start-ups, The Speech Improvement Company has developed a targeted curriculum and proven methodology designed specifically to help biotech executives develop the skills and approaches to deliver winning investor presentations.
Through team workshops and individual coaching, your presenters will learn time-tested, proven techniques to deliver memorable, persuasive, and successful presentations to biotech investment firms:
- Delivering technical information to non-technical investors
- Presenting as a cohesive management team
- Dealing with interruptions and hidden agendas
- Differentiating your company from other investment opportunities
- Using slides and other visual aids to add impact
Many of our coaches, including authors of this paper, have studied and taught communication at the graduate level or higher and collectively have written 13 communication-related books, including a comprehensive textbook in partnership with the National Communication Association on how to coach and train communication skills. When we say we’ve say “we’ve written the book” on how to be a speech coach, we have. Literally.
We are qualified to address biotech investor presentations because of our experience with, and knowledge of, human communication. From theories on how persuasion works, to the best ways to effectively connect with your listeners, we have studied it, written about it, discussed it, and filtered it through interactions with hundreds of companies both large and small.
We’re not a PR firm that also teaches presenters, and we don’t approach presentations from a theatrical background who see this as a form of acting. What they miss is the essence of persuasion, the field tests and studies on human reasoning, the current academic research on interpersonal communication, and a deep understanding of the interactions and thinking that occurs on both sides of the table.
The Speech Improvement Company will develop a custom training program based on your specific requirements. Through our peer-developed training with numerous biotech firms, we know the success factors and can help you determine the topics to address in your training.
Your training program can include a combination of several sessions, including:
Here are examples of topics our workshops and one-on-one coaching can address for you and your presentation team:
Since 1964, we've trained executives, managers, and individual contributors at startups to Fortune 500 firms, and have extensive experience with biotech and other life sciences companies. Our life sciences clients include:
Acceleron Pharma Inc.
Agios Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Boston Scientific Corporation
Brigham & Women's Hospital
Cadent Therapeutics, Inc.
Charles River Laboratories
Clal Biotechnology Industries
Constellation Pharmaceuticals, Inc.
Foundation Medicine, Inc.
Fulcrum Therapeutics, Inc.
Harvard University School of Medicine
HotSpot Therapeutics, Inc.
Infinity Pharmaceuticals, Inc.
Kymera Therapeutics LLC
Magenta Therapeutics, Inc.
Massachusetts General Hospital
Nimbus Therapeutics LLC
Novartis International AG
Obsidian Therapeutics, Inc.
Oxford Immunotec Global
Replimune Group, Inc.
Rodin Therapeutics, Inc.
Surface Oncology, Inc.
Syntonix Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc.
Takeda Pharmaceutical Company
Translate Bio, Inc.
Vertex Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc.